These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33107094)

  • 1. Endoscopies, blood-borne viruses and blood donors: time to move on from precaution.
    Hoad VC; Serhan G; Seed CR; Kiely P; Gosbell IB
    Vox Sang; 2021 Mar; 116(3):336-341. PubMed ID: 33107094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tattoos, blood-borne viruses and blood donors: a blood donor cohort and risk assessment.
    Hoad VC; Guy RJ; Seed CR; Harley R
    Vox Sang; 2019 Oct; 114(7):687-693. PubMed ID: 31396975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-transmissible infections among blood donors in Kathmandu, Nepal.
    Shrestha AC; Ghimire P; Tiwari BR; Rajkarnikar M
    J Infect Dev Ctries; 2009 Dec; 3(10):794-7. PubMed ID: 20009282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
    Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
    Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
    Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
    Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a national disaster on blood supply and safety: the September 11 experience.
    Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
    JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].
    Ankouane F; Noah Noah D; Atangana MM; Kamgaing Simo R; Guekam PR; Biwolé Sida M
    Transfus Clin Biol; 2016 May; 23(2):72-7. PubMed ID: 26791918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of transfusion transmissible viral infections (HIV, HBV and HCV) among voluntary blood donors at University of Gondar Comprehensive Specialized Hospital, Gondar; Northwest Ethiopia.
    Tigabu A; Engda T; Mekonnen F
    BMC Infect Dis; 2019 May; 19(1):393. PubMed ID: 31068138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.
    Zou S; Musavi F; Notari EP; Stramer SL; Dodd RY
    Transfusion; 2010 Jul; 50(7):1487-94. PubMed ID: 20345571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.